Clinical Trials List
2022-03-01 - 2029-12-31
Phase III
Recruiting4
ICD-10E10.21
Type 1 diabetes mellitus with diabetic nephropathy
ICD-10E11.21
Type 2 diabetes mellitus with diabetic nephropathy
ICD-10N16
Renal tubulo-interstitial disorders in diseases classified elsewhere
ICD-9583.81
Nephritis and nephropathy, not specified as acute or chronic, in diseases classified elsewhere
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 黃建中 風濕免疫科
- Po-Hao Huang 風濕免疫科
- 張詩欣 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Hsing Chen 無
- 譚國棟 Division of Rheumatology
- 謝佳偉 Division of Rheumatology
- 顏在弘 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- 吳沂達 Division of Rheumatology
- 洪維廷 Division of Rheumatology
- LIN-SHIEN Fu Division of Pediatrics
- HSIN-HUA CHEN Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- 曾智偉 Division of Rheumatology
- 廖育婉 Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 林靖才 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yi-Syuan Sun 無
- Wei-Sheng Chen Division of Rheumatology
- Chien-Chih Lai 無
- Hsien-Tzung Liao 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
420 participants
